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Objective: We previously showed that autologous myoblast sheets constructed with tissue-engineering
techniques improved the function of the impaired heart. In this study, we evaluated the effects of layered myoblast
sheets to clarify whether increasing the number of sheets provides improvement of cardiac function.
Methods:Myoblast sheets were constructed in dishes that release confluent cells from the dish surface via tem-
perature reduction. Sixty infarcted Lewis rats underwent implantation of myoblast sheets on the infarcted area.
There were 4 groups (n ¼ 15 in each group): S1: one layer, S3: three layers, S5: five layers, and a sham group.
We examined cardiac function by echocardiography and catheterization, mRNA expression by real time reverse-
transcriptase polymerase chain reaction, and histology.
Results: The ejection fraction and end-systolic pressure–volume relationship in the S5 and S3 groups were
significantly improved. End-diastolic area was significantly reduced in the S5 group. The mRNAs for
hepatocyte growth factor, vascular endothelial growth factor, and stromal cell–derived factor-1 were all up-
regulated in dose-dependent fashion. On histologic examination, fibrosis was most decreased in S5, and
vascular density was increased. Cellular hypertrophy was attenuated in both the S5 and S3 groups. Elastic
fibers were massively up-regulated in the infarction and implanted sheets in the S5 and S3 groups, with
expression of the elastin gene.
Conclusions: Implantation of three- and five-layered myoblast sheets yields favorable results, with better im-
provement of cardiac function, induction of angiogenesis, more elastic fibers, and less fibrosis. Thus, layered
myoblast sheets, in optimal numbers, may attenuate adverse cardiac remodeling of the infarcted heart.E
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SMyocardial regeneration therapy has been widely performed
for myocardial infarction (MI). Cell transplantation using
skeletal myoblasts has commonly been undertaken in animal
models as well as in clinical trials.1,2 Most myoblast trans-
plantation studies for cardiac failure have supported the feasi-
bility and safety of thismethod.3-6 In these studies, themethod
of cell transplantation was direct myocardial injection with
a fine needle. However, needle injection has some disadvan-
tages, including loss of transplanted cells by leakage, poor
survival of grafted cells, myocardial damage resulting from
injury by the needle and subsequent acute inflammation,7,8
and the potential to cause a lethal arrhythmia.6 To overcome
these disadvantages, we investigated the efficacy of a novel
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ture-responsive dishes.9 Myoblast sheets, without scaffold-
ing, were implanted to treat cardiac impairment in small and
large experimental animal models, and greater improvement
of cardiac function was observed as compared with that ob-
tained by needle injection and control groups.10-13
However, the method of cell delivery in these studies had
several limitations, including the implantation method (im-
planting two-layered myoblast sheets with collagen film to
keep the sheets on the heart) and delivery of an optimal num-
ber of cells. It has been unclear whether delivery of more cells
will be more effective in inducing cardiac regeneration. It has
also not been clearly determined whether increasing the num-
ber of layers would yield better results. Shimizu and co-
workers14 reported that transplanted three-layered sheets of
cardiomyocytes could be vascularized in subcutaneous tissue
without necrosis, but that sheets with four or five layers have
areas with disorganized vasculature and primary ischemia.
Our previous reports10,11 showed that implantation of
two-layered, autologous myoblast sheets improved cardiac
function and prevented remodeling of the infarcted heart.
In this study, we tested whether increasing the number of
layered myoblast sheets would enhance functional recovery
and attenuate adverse cardiac remodeling of the infarcted
heart to estimate the optimal number of myoblast sheet
layers for regeneration of host heart.ardiovascular Surgery c Volume 138, Number 4 985





HGF ¼ hepatocyte growth factor
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
MI ¼ myocardial infarction
RT-PCR ¼ reverse-transcription polymerase
chain reaction
SDF-1 ¼ stromal-derived factor 1
VEGF ¼ vascular endothelial growth factor
MATERIAL AND METHODS
Isolation of Myoblasts and Construction of Myoblast
Sheets
Myoblasts were isolated from the skeletal muscle of the anterior tibialis
from 3-week-old male Lewis rats. The rats were humanely killed, and their
skeletal muscles were excised andwashed with Hanks balanced salt solution
(Gibco, Grand Island, NY) containing 13 penicillin–streptomycin–ampho-
tericin B (PSA; Gibco). After the removal of as much fibrous tissue,
tendons, and fat tissue as possible, the muscles were minced and enzymat-
ically dissociated with collagenase type II (Gibco) (5 mg/mL) and trypsin–
ethylenediaminetetraacetic acid (Gibco) for 30 minutes. The cells were
collected by centrifugation (5 minutes at 280g), and the enzyme reaction
was arrested by adding 20% fetal bovine serum (ICN Biomedicals, Aurora,
Ohio), after which the cells were spun again. The supernatant was discarded
and the cells were resuspended in culture medium composed of Dulbecco
modified Eagle solution (Gibco) with 20% fetal bovine serum and 1% pen-
icillin–streptomycin–amphotericin B. The initial plating was performed in
noncoated 150-mm dishes (Iwaki, Tokyo, Japan) for 4 hours. Secondary
plating was performed in noncoated dishes for 20 hours. After being
pre-plated twice, the nonadherent cells were placed in collagen-coated
150-mm dishes (Iwaki) and incubated for 3 days, after which cell passaging
was performed into five collagen-coated dishes. When the cells became
approximately 70% confluent after 7 days’ cultivation, they were dissoci-
ated from the dishes with trypsin–ethylenediaminetetraacetic acid and
reincubated on 35-mm temperature-responsive culture dishes (UpCell;
Cellseed, Tokyo, Japan) at 37C, with cell number adjusted to 3.0 3 106
per dish. More than 70% of these cells were actin-positive and 40% to
50% were desmin-positive (Figure 1, A to D). After 24 hours, the dishes
were incubated at 20C for 30 minutes. During that time, the myoblast
sheets detached spontaneously to generate free-floating, monolayer cell
sheets. After detachment, the area of the sheets decreased to 1.00  0.05
cm2, whereas the thickness increased to 100  10.0 mm (Figure 1, E).
Animals and Surgical Procedures
Eight-week old male Lewis rats were used (220–250 g; Seac Yoshitomi
Ltd, Fukuoka, Japan). All experimental procedures and protocols used in
this investigation were reviewed and approved by the institutional animal
care and use committee and are in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Animals (NIH Publica-
tion No. 85-23, revised 1996). The rats were anesthetized with ketamine
(90 mg/kg) and xylazine (10 mg/kg), and MI was induced by ligation of
the left anterior descending coronary artery under mechanical ventilation,
as previously described.15 Two weeks after the ligation, baseline cardiac
functions were measured, and the infarcted rats underwent implantation
of myoblast sheets via rethoracotomy. The rats were randomly divided
into 4 treatment groups: (1) S1 group (one-sheet implantation); (2) S3 group
(three-sheet implantation; (3) S5 group (five-sheet implantation); and
a sham group (sham surgery alone). The myoblast sheets were implanted
directly over the scar area without sutures. After detachment from the986 The Journal of Thoracic and Cardiovascular Sutemperature-responsive dish, each sheet was picked up individually and
applied to the surface of the heart. So that the sheet could be spread, the
folded areas were gently stroked with wet, round tip forceps. After 3 to 5
minutes, subsequent sheets were applied by the same technique. After
treatment, the pericardium was overwrapped by suturing with 8–0 Prolene
polypropylene suture (Ethicon, Inc, Somerville, NJ) to prevent sheets from
adhering to the chest wall.
Assessment of Cardiac Function
Left ventricular (LV) function of the treated rats was monitored by
echocardiography 4 and 8 weeks after myoblast sheet implantation
and compared with results before implantation (baseline). Cardiac ultra-
sonography was performed with a SONOS 5500 sonograph (Agilent
Technologies, Palo Alto, Calif) using a 12-MHz annular array trans-
ducer under anesthesia with diethyl ether. The hearts were imaged in
short-axis 2-dimensional views at the level of the papillary muscles,
and LV end-systolic area, LV end-diastolic area, and the LV dimen-
sions at end-systole and end-diastole (LVDs, LVDd) were determined.
Fractional shortening was determined as ([LVDd  LVDs]/LVDd) 3
100. Ejection fraction (EF) was calculated by the Pombo method, as
EF (%) ¼ ([LVDd3  LVDs3]/LVDd3) 3 100.
Eight weeks after implantation, the rats were anesthetized and placed in
a supine position on a controlled heating pad, and core temperature,
measured via a rectal probe, was maintained at 37C  1C. A MicroTip
catheter transducer (SPR-671; Millar Instruments, Inc, Houston, Tex) and
conductance (Unique Medical Co, Tokyo, Japan) catheters were placed
longitudinally in the left ventricle from the apex. We connected the
catheters to an Integral 3 signal conditioner–processor (Unique Medical
Co, Tokyo, Japan). LV pressure and volume and the electrocardiogram
were displayed and digitized on a personal computer. LV pressure–volume
relations were measured by transiently compressing the inferior vena cava.
Data were recorded as a series of pressure–volume loops (about 20 loops).
The pressure–volume loop data were analyzed with Integral 3 software
(Unique Medical Co).16
Histologic Examination
LV myocardial specimens were obtained 4 weeks after sheet implan-
tation. Each specimen was fixed with 10% buffered formalin and embed-
ded in paraffin. Hematoxylin and eosin and Masson’s elastica staining
were performed. Picrosirius red staining to detect myocardial fibrosis
and periodic acid–Schiff staining for cardiomyocyte hypertrophy were
performed for specific treatment groups, as described.17 Anterior wall
thickness was measured in at least 3 hematoxylin and eosin–stained
sections of the middle portion of the left ventricle of each heart. To label
vascular endothelial cells, so that blood vessels could be counted, we
performed immunohistochemical staining for factor VIII–related antigen
according to a modified protocol. We used EPOS-conjugated antibody
to factor VIII–related antigen coupled with HRP (Dako EPOS Anti-hu-
man von Willebrand Factor/HRP; Dako, Carpenteria, Calif) as primary
antibody. The stained vascular endothelial cells were counted under
a light microscope. Results were expressed as the number of blood
vessels per square millimeter. Quantitative morphorometric analysis for
each sample was performed with MacScope software (Mitani Corpora-
tion, Tokyo, Japan). Myocardial fibrosis was expressed as percent fibro-
sis, the fraction of red-stained area in total myocardium, with results
obtained from 10 fields per section per animal. To determine myocyte
cell size, we randomly selected 10 fields from each ventricle and
measured 5 randomly chosen myocytes per field.
Measurement of Growth Factors and Elastin Gene
Expression After Implantation
Infarcted and noninfarcted LV myocardium from the rats having
a ligated left anterior descending coronary artery was removed 4 weeksrgery c October 2009
Sekiya et al Evolving Technology/Basic ScienceFIGURE 1. Cultured myoblasts and cross section of a sheet. Almost all cultured cells were actin-positive (A), and roughly 40% to 50% of them were
desmin-positive muscle lineage cells (B). DAPI (4,6-diamino-2-phenylindole) staining of nuclei (C), and merged image (D) (A–D; magnification 310,
bar ¼ 100 mm). Toluidine blue staining of cross section of sheet-constructed cells (E) (bar ¼ 100 mm).E
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Safter implantation and immediately stored in RNAlater solution (Qiagen,
Hilden, Germany) until use (n ¼ 10 for each of the 4 groups, S1, S3, S5,
and sham). Total RNA was extracted with the RNeasy mini kit (Qiagen),
and relative levels of mRNA transcripts were measured by the real-time
quantitative reverse-transcriptase polymerase chain reaction (RT-PCR)
technique using the ABI PRISM 7700 Sequence Detection System
(Applied biosystems, Carlsbad, Calif).18 The average copy number of
gene transcripts in each sample was normalized to that for glyceralde-
hyde-3-phosphate dehydrogenase, and fold induction of each gene was
calculated by the formula: Fold induction ¼ Normalized value in a sam-
ple after MI/Mean of the normalized values for 15 reference myocardial
samples.
Data Analyses
All values are the mean  standard error of the mean. To assess the sig-
nificance of differences between individual groups, we performed statistical
evaluations with multiple analyses of variance. Differences in cardiac func-
tion data obtained by echocardiography were assessed by 2-way repeated-
measures analysis of variance. If a significant F ratio was obtained, further
analysis was carried out with a post hoc test.The Journal of Thoracic and CRESULTS
Layered Myoblast Sheet Implantation Improved
Cardiac Performance
Echocardiography revealed significant improvement of
LV ejection fraction (LVEF) and percentage fractional
shortening in the S3 and S5 groups compared with the S1
and sham groups 4 and 8 weeks after implantation. The
LVEF 4 weeks after implantation in the S5 group was signif-
icantly improved compared with that in the S3 group (P<
.05) (Figure 2, A and B). Enlargement of LV end-diastolic
area was significantly attenuated in the S5 group compared
with the sham and S1 groups at 4 weeks and differed signif-
icantly from the sham group 8 weeks after implantation (Fig-
ure 2, C). The end-systolic pressure–volume relationship
was significantly improved in both the S3 and S5 groups
compared with the S1 and sham groups 8 weeks after im-
plantation (Figure 2, D). Thus, implantation of sheets of atardiovascular Surgery c Volume 138, Number 4 987




SFIGURE 2. Cardiac function after layered myoblast sheet implantation. Echocardiographic measurements of rat heart (A–C). Baseline represents 2 weeks
after left anterior descending coronary artery ligation. The pressure-volume study was performed at 8 weeks after treatment to estimate the systolic function of
rat heart (D). *P<.05 versus sham group. yP< .05 versus S1 group. #P< .05 versus S3 group. EF, Ejection fraction; FS, fractional shortening; EDA, end-
diastolic area; ESPVR, end-systolic pressure-volume relationship.least three layers improved systolic function of the impaired
heart, although only implantation of five-layered sheets at-
tenuated enlargement of the left ventricle after infarction.
Histologic Improvement of Host Heart After
Myoblast Sheet Implantation
Anterior wall thickness increased in a dose-dependent
fashion. Three- and five-sheet implantations significantly
thickened the infarcted wall compared with other conditions
(P<.05) (Figure 3, A to D, and Figure 4, A). In the infarcted
region 4 weeks after implantation, vascular density was sig-
nificantly higher in the S3 and S5 groups than in the S1 and
sham groups (P<.05). There was no significant difference in
density between the S3 and S5 groups (Figure 3, E toH, and
Figure 4, B). In noninfarcted regions at 4 weeks, picrosirius
red staining revealed significant reduction of fibrosis in the
S3 and S5 groups compared with the S1 and sham groups.
The fibrosis in the S5 group was significantly reduced com-
pared with that in the S3 group (Figure 3, I to L, and Figure 4,
C). The mean diameters of the myocytes in the S3 and S5
groups were smaller than those in the S1 and sham groups
(P< .05) (Figure 3, M to P, and Figure 4, D).
Assessment of Growth Factors by Gene Expression
RT-PCR analysis 4 weeks after implantation revealed
significantly higher expression of stromal-derived factor 1
(SDF-1) in the S5 group than in the other groups (P<
.05). Although expression of vascular endothelial growth
factor (VEGF) increased in each group in a dose-dependent
fashion, there were no significant differences among groups.988 The Journal of Thoracic and Cardiovascular SurThe hepatocyte growth factor (HGF) gene was expressed to
significantly higher levels in the S1, S3, and S5 groups than
in the sham group (Figure 5). Thus, the hearts implanted with
myoblast sheets expressed angiogenetic factors in a dose-
dependent fashion, and increasing the number of myoblast
sheets yielded greater expression of growth factors.
Increase in Elastic Fibers in Implanted Area With
Expression of Tropoelastin mRNA
Masson’s elastica staining showed that elastic fibers had
increased not only in the implanted sheet layers but also in
the infarcted scar area. In the S5 and S3 groups, the im-
planted sheets including elastic fibers surrounded the host
heart over the infarcted area (Figure 6, A to D). In contrast,
they were scarce in the S1 and sham groups (Figure 6, E and
F). The relative expression of rat tropoelastin mRNA in-
creased in a dose-dependent fashion. Expression in the S5
group was significantly higher than those in the sham and
S1 groups (P< .05) (Figure 6, G).
DISCUSSION
In this study, we examined whether increasing the number
of cell sheets used to attenuate cardiac remodeling and repair
an infarcted myocardial wall improved cardiac performance.
We found that implantation of five-layered myoblast sheets
yielded favorable results, with improvement of cardiac func-
tion, induction of angiogenesis, less fibrosis, and less hyper-
trophy than the single-layered sheets used in this study or
the two-layered sheets used in previous studies.10,11 Sheet-
shaped tissue maintains intact membrane and adhesivegery c October 2009
Sekiya et al Evolving Technology/Basic ScienceFIGURE 3. Histologic findings of implanted host hearts. Macroscopic (320) view of anterior wall of hearts (hematoxylin and eosin stain): sham, A; S1, B;
S3, C; S5, D (bar ¼ 200 mm). Sections of infarcted regions were stained with antibody to von Willebrand factor (factor VIII): sham, E; S1l F; S3, G; S5, H
(bar¼ 100 mm). Sirius-red staining of myocardium of noninfarcted regions: sham, I; S1, J; S3, K; S5, L (bar¼ 100 mm). Periodic acid–Schiff–stained myo-
cardium of noninfarcted regions: sham, M; S1, N; S3, O; S5, P (bar ¼ 50 mm).E
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Sproteins, incorporates extracellular matrix molecules, se-
cretes growth factors owing to favorable cell-to-cell cross-
talk, and prevents cellular microenvironment disruption by
enzymatic reactions typically used to detach cells from tis-
sue culture dishes (eg, trypsin or dispase).19 These new tis-
sue-engineered cell sheets are expected to be useful for
cell delivery to the heart.6,1,12
Cardiac remodeling after MI appears to be compensatory
initially, but has generally adverse effects and is linked to the
progression of heart failure. Cardiomyocyte hypertrophy
and interstitial fibrosis are usually observed in the remodeled
heart, and greater ventricular enlargement correlates with
a poorer prognosis for patients with coronary artery dis-
ease.20,21 It is, therefore, now widely believed that ventricu-
lar remodeling is an important therapeutic target in patientsThe Journal of Thoracic and Cwith MI. Here, we treated MI hearts by implantation of lay-
ered myoblast sheets and observed decreased remodeling.
The mechanism of this attenuation of remodeling may in-
volve efficient delivery of myoblast sheets that overlap the
scar area and its borders in the form of a cellular bridge.11
Expression of HGF, VEGF, and SDF-1 increases in the
host heart implanted with myoblast sheets.11 Therefore,
layered myoblast sheets may be good suppliers of these fac-
tors for impaired hearts. HGF prevents the ventricular re-
modeling of hearts with established experimental MI.22-25
Our previous findings suggested that SDF-1 is released
from myoblasts, recruits hematopoietic stem cells, and facil-
itates repair of the infarcted heart. Similarly, the increased
release of HGF and VEGF in the S3 and S5 treatment groups
of the current study might have had advantageous effects inardiovascular Surgery c Volume 138, Number 4 989




SFIGURE 4. Quantitative assessment of histologic findings. A, Assessment of anterior wall thickness after implantation. B, Assessment of vascular density in
the infarcted area of host hearts vascular density. C, Quantitative results for fibrotic change in the left ventricle. D, Cardiomyocyte short-axis diameters were
measured as described inMethods (n¼ 5 for each group: A–D, 10 randomly chosen fields per section: B–D). *P<.05 versus sham group. yP<.05 versus S1
group. #P<. 05 versus S3 group.the damaged heart. On histologic examination, microvessels
were increased in the infarcted areas implanted with myo-
blast sheets. This increased angiogenesis, likely caused by
increased HGF, VEGF, and SDF-1, may have improved
the microenvironment of the myocytes, rescuing them
from cell death or scar formation.990 The Journal of Thoracic and Cardiovascular SurElastin is a major insoluble extracellular matrix compo-
nent. The elastic fiber network provides tissue with the crit-
ical properties of elasticity and resilient recoil and maintains
the integrity of tissue architecture against repeated expan-
sion.26,27 Mizuno and colleagues28 reported that transplanta-
tion of elastin gene–transfected cells attenuated adverseFIGURE 5. Relative expression of growth factors (A–C). Relative levels of mRNA transcripts were measured by the real-time quantitative RT-PCR (n¼ 10
for each of the four groups, S1, S3, S5, and sham). The average copy number of gene transcripts in each sample was normalized to that for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). *P< .05 versus sham group. yP< .05 versus S1 group. HGF, Hepatocyte growth factor; VEGF, vascular endothelial
growth factor; SDF-1, stromal-derived factor-1.gery c October 2009
Sekiya et al Evolving Technology/Basic ScienceFIGURE 6. Elastic fibers were constructed after implantation, with expression of mRNA. Elastic fibers were increased in sheets and host infarcted area in the
S5 and S3 groups (S5, A and B; S3, C and D). There were few elastic fibers in the S1 and sham groups (S1, E; sham, F). Relative expression of mRNA of
tropoelastin (G). *P< .05 versus sham group. yP< .05 versus S1 group.E
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Scardiac remodeling of the infarcted heart. The underlying
mechanism may involve the addition of elasticity to the in-
farcted area, permitting recoil in response to the stresses of
contraction, which might reduce scar thinning and dilatation.
In our studies, implanted myoblast sheets organized elastic
fibers not only in the sheet cells but also in the infarcted
area of the host heart. Layered myoblast sheet cells might or-The Journal of Thoracic and Cganize the elastic fibers within the cell sheets and infarcted
area via expression of tropoelastin, which was expressed
more strongly in the layered implantation groups (S3 and
S5). It may thus provide elasticity to the host heart, with
the improvement of systolic function and less LV dilatation.
We have never detected procedure-induced arrhythmia in
these animal models.11-13 Menasche´ and associates6 reportedardiovascular Surgery c Volume 138, Number 4 991




Sthat sustained ventricular tachycardia might be an adverse ef-
fect after myoblast injection. The implantation of myoblast
sheets seems to be safe in this regard. We speculate that myo-
blasts implanted into the heart may have the potential to cause
random electrical activity, causing lethal arrhythmia. On the
other hand, myoblast sheets implanted outside the epicardium
may not generate sufficient aberrant electrical activity to cause
lethal arrhythmia. Of course, this is speculation and further in-
vestigation, including electrophysiologic studies, is needed.
One of the limitations of this study is that implantation of
more than five layers of myoblast sheets was not investigated.
However, we tested ten-layered–sheet implantation in this
model and found that the LVEF in this group improved to
the same level as seen in the S5 group 4 and 8 weeks after
implantation (Sekiya and Sawa; unpublished results). This
suggests that improvement of cardiac function may plateau
at five layers because of the insufficient supply of oxygen
and nutrition for myoblasts. This contrasts with the study
of Shimizu and associates,14 who found that a maximum of
three layers could be implanted at one time using cardiomyo-
cyte sheets. Therefore, myoblasts may have a higher toler-
ance against ischemia and/or hypoxia than cardiomyocytes,
and five-layered sheets could be more optimal than three-
layered sheets when myoblast sheets are implanted.
Another limitation is of the current study is that the fate of
the implanted cells was not tracked. We have begun address-
ing this by examining sheet cell survival 4 weeks after
implantation. In brief, we transplanted male-derived cell
sheets onto 15 female infarct hearts that were divided into
three groups (S1, one sheet; S3, three sheets; S5, five sheets;
n ¼ 5 in each group). Four weeks later, genomic DNA was
purified from the whole heart, and the male-specific SRY
gene, which represented the implanted cells and their deriv-
atives, was measured by real-time quantitative PCR.29 The
expression ratio of SRY to interleukin 2 gene was as follows
(%): S1 (0.05  0.01)<S3 (0.22  0.10, P< .05 vs S1)<
S5 (0.86  0.16, P< .05 vs S1, S3) (n ¼ 5, each group)
(Sekiya and Sawa; unpublished results). From these results,
we found that more cells survived on the host heart 4 weeks
after implantation when a greater number of sheets were
implanted. This fact could not directly assess the sheet cell
survival on male donor rats. However, we believe that
layered sheet implantation yields dose-dependent cell sur-
vival after implantation. Although we do not yet know the
phenotype of these implanted cells, the survival data were
compatible with the dose-dependent growth factor expres-
sion and increased wall thickness seen in the experiments
presented here.
We propose the following mechanism of repair of the
infarcted heart by layered myoblast sheets. At first, the im-
planted sheets might provide angiogenic and cardioprotec-
tive factors, such as HGF, VEGF, and SDF-1, to the host
heart. These factors induce angiogenesis in the infarcted
area. Additionally, the myoblast sheets mechanically cover992 The Journal of Thoracic and Cardiovascular Surthe infarcted area and increase its thickness. Then, the im-
planted sheet cells express the elastin gene and form elastic
fibers both in the sheets and in the host heart. The repaired
heart, in turn, exhibits reduced wall stress, and LV dilata-
tion, fibrosis, and hypertrophy are prevented.
Recently, we30 have investigated 3-dimensional cell sheet
construction in vitro using combinations of several different
kinds of cells, such as endothelial cells and fibroblasts, aim-
ing to induce vasculogenesis in cell sheets. In the future,
beating cell sheets differentiated from pleuripotent stem
cells, expressing connexin 43, and containing endothelial
cells might be applied to the impaired heart and yield even
greater improvement of cardiac function via different mech-
anisms, such as direct mechanical support through gap junc-
tions, than those reported here.
In summary, our study demonstrated that implantation of
myoblast sheets with five layers significantly improved LV
systolic function for at least 2 months. Although the mecha-
nism of this effect is not yet clear, a paracrine activity might
induce angiogenesis and reduce fibrosis and hypertrophy.
Elastic fibers in the cell sheets or host heart might mechani-
cally improve the function of the infarcted heart. Thus, layered
myoblast sheets, in optimal numbers, may improve cardiac
function and attenuate adverse cardiac remodeling in the in-
farcted heart. A clinical trial is desired in the near future.
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